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Abstract We have investigated the role of JAK3 in interleukin 2 (IL-2)-induced signal transduction with a human T cell line, ED40515(-), lacking 
expression of the IL-2 receptor y chain and its sublines transfected with wild-type or mutant cDNAs of the IL-2 receptor y chain. Our results 
demonstrated that the membrane-proximal cytoplasmic region, encompassing the src homology region 2 (SH2)-like subdomain, of the y chain is 
essential for association and activation of JAK3. Furthermore, IL-2-induced activation of JAK3 paralleled induction of the c-myc gene and DNA 
synthesis but not induction of the c-fos and c-jun genes. These results upport he hypothesis that JAK3 plays a pivotal role in the IL-2 receptor- 
mediated signals for cell growth. 
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1. Introduction 
The functional IL-2 receptor (IL-2R) is known to be a 
heterotrimer composed of the ~, fl and y chains or a hetero- 
dimer of the fl and y chains, indicating that the fl and y chains 
are essential for formation of the functional IL-2R [1]. The fl 
and y chains belong to the cytokine receptor family which has 
no catalytic domain like kinases. IL-2 induced, however, tyro- 
sine phosphorylation f the fl and 7 chains of IL-2R [2,3] and 
of cellular proteins [4-8], and the IL-2R complex contained 
tyrosine kinase activity [3,9,10]. 
During studies to identify tyrosine kinase(s) associated with 
the IL-2R complex, src type tyrosine kinases, Lck, Lyn and 
Fyn, were demonstrated to be activated by IL-2 stimulation 
[11 13], and, in particular, Lck was shown to bind directly to 
the so-called acidic region of theft chain [14]. However, it is not 
yet determined whether such src type tyrosine kinases are in- 
volved in IL-2-induced cell growth promotion, because a fl 
chain mutant lacking the acidic region, which does not associ- 
ate with Lck, still retains the ability to transduce cell growth 
signal in an I L-2-dependent manner [15,16]. 
There is accumulating evidence that cytoplasmic tyrosine 
kinase of JAK-Tyk family, such as JAK1, JAK2 and Tyk2, are 
involved in signal transduction mediated by some cytokines 
including interferon (IFN) ct/fl and y [17-21], erythropoietin 
(EPO) [22], growth hormone (GH) [23], interleukin 3 (IL-3) 
[24], interleukin 6 (IL-6), ciliary neurotrophic factor (CNTF), 
leukemia inhibitory factor (LIF), oncostatin M (OSM) [25,26] 
and granulocyte-colony-stimulating f ctor(G-CSF) [27]. In this 
context, we have asked whether the JAK-Tyk family is asso- 
ciated with the IL-2/IL-2R system, and recently found that 
JAK1 and 114 kDa JAK2-related kinases are physically associ- 
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ated with the fl chain and the ?' chain, respectively, and at least 
the 114 kD JAK2-related kinase is activated by IL-2 stimula- 
tion [28]. Very recently a novel member of JAK-Tyk family, 
JAK3 or L-JAK was cloned [29,30]. The present study using 
anti-JAK3 antibody demonstrated that the 114 kDa JAK2- 
related kinase associated with the y chain of IL-2R is identical 
to JAK3, and further demonstrated the significant roles of 
JAK3 in IL-2-mediated signals for induction of the c-myc gene 
and DNA synthesis. 
2. Materials and methods 
2.1. Plasmid construction 
Expression vector plasmids used are pSRGI containing the wild-type 
y chain cDNA of IL-2R, pSRGdC30 and pSRGdC68 containing 
ydC30 and ydC68 mutant y chain cDNA deleted of the C-terminal 30 
and 68 amino acids, respectively [31]. pSRGdSH contains ydSH mutant 
y chain cDNA deleted of the SH2-1ike subdomain. For the deletion of 
the SH2-1ike subdomain of the y chain, the 136-bp EcoRI HinfI frag- 
ment was removed from pSRG1 and the resultant plasmid vector was 
ligated after T4 DNA polymerase treatment. 
2.2. Cell lines 
ED40515(-), previously referred to as ED515-I, is a subclone of 
ED40515, an HTLV-I transformed human T cell line [32]. ED40515(-) 
expresses the ~ and 1~ chains of IL-2R but not the IL-2R y chain and 
proliferates independently of IL-2 [33]. EDy cell lines (EDy-2, -15 and 
-16) were independently established from ED40515(-) by transfection 
with a vector plasmid, pSRG1. EDydC30, ED~'dC68 and ED~,dSH cell 
lines (EDydC30-1, -2 and -4, EDydC68-3, -5 and -7 and EDydSH-1, 
-6 and -10) were similarly established from ED40515(-) by stable trans- 
fection with pSRGdC30, pSRGdC68 and pSRGdSH plasmids. All the 
cell lines were maintained in RPMI 1640 medium supplemented with 
10% fetal calf serum (FCS) and antibiotics. 
2.3. Antibodies 
TUll and TUGh4 mAbs are specific for the human IL-2Rfl chain 
[34] and human 1L-2Ry chain [35], both of which do not interfere with 
IL-2 binding to IL-2R. PAR3 mAb against human parvovirus B19 was 
used as a control [36]. Anti-JAKl and anti-JAK2 antibodies specific for 
murine JAK1 and JAK2, which are cross-reactive to human JAKI and 
JAK2, respectively, and 4GI0 mAb specific for phosphotyrosine w re 
purchased from UBI (Lake Placid, NY). Anti-rat JAK3 antibody was 
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obtained with immunization of rat JAK3 synthetic peptide (Asp ~69 
GlylS2). 
2.4. [~H]Thymidine incorporation assay 
Short-term cell proliferation in response to IL-2 were measured by 
[3H]thymidine incorporation assays. Cells (2 × 104) were cultured in 200 
/11 of medium containing 0.5% FCS in the presence of IL-2 at indicated 
concentrations for 72 h in triplicate. [3H]Thymidine was added at 1.0 
~tCi per well 4 h before termination of incubation. The incorporated 
[3H]thymidine was counted with a liquid scintillation counter. 
2.5. Northern ( RNA ) blotting and probes 
Total cellular RNA was isolated by extraction with guanidium thio- 
cyanate from cells stimulated with 10 nM IL-2. Northern blot hybrid- 
ization and probes were described previously [31]. 
5- 
2.6. lmmunobloning 
Cells were incubated for 5 min in the presence or absence of l0 nM 
of IL-2, and then lysed with NP-40 cell extraction buffer or digitonin 
cell extraction buffer (1% digitonin, 150 mM NaCI, 10 mM trietha- 
nolamine, 10 mM iodoacetamide, 1 mM EDTA and 20 pg/ml aprot- 
inin). Cell lysates were immunoprecipitated with indicated antibodies. 
The immunoprecipitates w re separated by SDS-PAGE and transferred 
to PVDF filters (Millipore, Japan). After incubation in PBS containing 
2% BSA, the filters were then incubated with indicated antibodies, 
followed by incubation with ~2SI-labeled protein A (1CN, Costa Mesa, 
CA). 
2. 7. In vitro immunecomplex kinase assay 
The immunoprecipitates w re suspended inthe kinase reaction buffer 
[10 mM HEPES (pH 7.5), 50 mM NaC1, 0.1 mM Na~VO4, 5 mM 
MgCI2, 5 mM MnCI2, 0.5 mM DTT, 0.1% Triton X-100]. The kinase 
reaction was started by addition of 10 ,uCi of [y32p]ATP ( > 5000 Ci/ 
mmol, Amersham) and continued for 10 min at 22°C. The reaction was 
terminated by addition of 20 pl of SDS gel loading buffer. 
3. Results and discussion 
3.1. Effects of  mutant y chains on IL-2-mediated signal 
transduction 
A human T cell line, ED40515(-), expresses the IL-2R ~ and 
fl chains, but is undetectable in expression of the ), chain at 
either protein or mRNA level ([33], our unpublished ata). The 
wild-type y chain and its cytoplasmic deletion mutants were 
stably introduced into ED40515(-) cells by electroporation. 
The mutants are ydC30 lacking C-terminal 30 amino acids, 
ydC68 lacking the C-terminal 68 amino acids and ydSH lacking 
the SH2-1ike subdomain. The SH2-1ike subdomain is intact in 
ydC30, but it is abolished in ydC68. We picked up representa- 
tives of the ED40515(-) transfectants with the wild-type, 
7dC30, 7dC68 and TdSH, and renamed EDy, EDydC30, 
EDTdC68 and EDTdSH, respectively. Expression of the trans- 
fected y chains on the clones was confirmed by immunostaining 
and immunoprecipitation with TUGh4, a monoclonal antibody 
(mAb) specific for the human IL-2Ry chain (data not shown). 
We examined the effects of IL-2 on growth of the transfec- 
tants. Incorporation of [3H]thymidine was monitored by using 
three independent clones of each transfectant with the wild-type 
or mutant y chains. Cells (2 x l0  4 cells/well) in microplates were 
stimulated with indicated doses of IL-2 and labeled with 
[3H]thymidine for 4 h. IL-2 induced [3H]thymidine incorpora- 
tion in three clones, EDy-2, -15 and -16, of the wild-type y chain 
transfectant in an IL-2-dose-dependent manner. Similar incor- 
poration was seen with three clones, EDydC30-1, -2, and -4, of 
the transfectant with ?,dC30, however no incrase in [3H]thymid- 
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Fig. 1. [~H]Thymidine incorporation assay. Cells (2 x 104) were cultured 
at various concentrations of IL-2 and measured for incorporation of 
[3H]thymidine in triplicate. Stimulation indexes represent the ratios of 
radioactivity of incorporated [3H]thymidine in the presence of IL-2 to 
that in the absence of 1L-2. ED40515(-), ED),-2, -15 and -16, 
EDTdC30-1, -2 and -4, EDydC68-3, -5 and -7, EDydSH-1, -6 and -10 
in medium containing 0.5% FCS without IL-2 gave [3H]thymidine in- 
corporation of 39,710 + 3,258, 30,430 + 743, 42,035 + 1,395, 33,611 + 
929, 21,405 + 1,151, 39,787 + 1,424, 45,682 + 857, 24,390 + 1,330, 
34,699 + 3,052, 24,930 + 2,070, 28,58 + 2,220, 26,604 + 3,018 and 
30,336 + 3,704 cpm + S.E.M., respectively. Each plot represents the 
mean value + S.E.M. of incorporated [~H]thymidine in triplicate. 
transfectants and EDydSH- 1, -6 and -10 transfectants as well 
as in ED40515(-) cells (Fig. 1). 
The transfectants were further investigated for their expres- 
sion of nuclear proto-oncogenes, c-fibs, c-jun and c-myc, which 
is another parameter of IL-2-dependent signals. Transfectant 
cells were cultured in the presence of 10 nM IL-2. Total RNA 
was extracted from those cells and subjected to Northern blot 
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Fig. 2. IL-2-dependent mRNA expression ofnuclear proto-oncogenes 
in the transfectants. Cells were stimulated with 10 nM IL-2 for the 
indicated times and harvested for RNA preparation. 30/.tg of total 
RNAs were loaded on agarose gel electrophoresis. After blotting to a 
nylon filter, the filter was incubated with indicated 32p-labeled probes. 
The relative amount of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA was monitored to check the amount of total RNA 
applied to each lane. 
analysis with appropriate probes (Fig. 2). mRNA for the c-fos 
and c-jun genes in ED7-16 cells was induced by IL-2 stimula- 
tion, and expression of mRNA for the c-myc gene was 
enhanced, similar to the mouse fibroblastoid L929 cell transfec- 
tant reconstituted with the high-affinity IL-2 receptor by trans- 
fection with the wild ~, fl and y chains [31]. No effect of IL-2 
was seen with EDTdC68-3 EDTdSH-1 and ED40515(-) cell 
lines. Interestingly, IL- 2-dependent enhancement of c-myc 
mRNA was segregated from induction of c-fos and c-jun 
mRNA in EDTdC30-4 cells. 
These results indicate that the membrane-proximal cytoplas- 
mic region including the SH2-1ike subdomain of the 7 chain is 
required for IL-2-mediated signal transduction for cell growth 
and enhancement of the c-myc gene, whereas the region of the 
C-terminal 30 amino acids of the 7 chain is essential for induc- 
tion of the c-fos and c-jun genes but not for enhancement of he 
c-myc gene and cell growth. 
3.2. Association of JAK1 and the 114 kD JAK2-related molecule 
with the fl and 7 chains 
Transfectants were lysed with digitonin lysis buffer, and the 
fl and g chains were then immunoprecipitated with TU11 and 
TUGh4, respectively. As controls, ED40515(-) cells were im- 
munoprecipitated with a control mAb, PAR3, and with anti- 
JAK1 or anti-JAK2 antibody. The immunoprecipitates werre 
separated by SDS-PAGE and transferred to filters which were 
then immunoblotted with anti-JAK2 antibody. A band with an 
apparent molecular mass of 114 kDa was detected in the 
TUGh4-directed immunoprecipitates from EDy-16 and 
EDTdC30-4 (Fig. 3, upper panel, lanes 2 and 3). No band was 
associated with the immunoprecipitates from EDydC68-3 and 
EDTdSH-1, and with fl chains which were immunoprecipitated 
with the TUI 1 from all cell lines. These results demonstrated 
that the 114 kDa JAK2-related molecule directly or indirectly 
links to the membrane-proximal cytoplasmic region, encom- 
passing the SH2-1ike subdomain, of the y chain. As expected, 
the 114 kD JAK2-related molecule was not detected in the 
immunoprecipitates by a control antibody, PAR3, and an anti- 
JAK1 antibody. 
The procedure of immunoblot with anti-JAK2 antibody de- 
tected two major bands (120 kDa and 97 kDa) and two minor 
bands (114 kDa and 102 kDa) with the anti-JAK2 antibody- 
directed immunoprecipitate using lysates from ED40515(-) 
(Fig. 3, lane 13). All four bands were eliminated by pretreat- 
ment with tbe synthetic oligopeptides from murine JAK2, 
which were immunized to generate anti-JAK2 antibody used 
in this study (data not shown), indicating that the four mole- 
cules are specifically precipitated by anti-JAK2 antibody. 
Among them only the minor 114 kDa JAK2-related molecule 
seemed to be associated with the y chain. 
We have recently found that the fl chain is associated with 
JAK1 [28]. Thus, association of JAK1 with the fl chain was 
examined with the transfectants bearing the wild-type and mu- 
tant y-chains (Fig. 3, lower panel). The band corresponding to 
JAK1 was seen with the TU11- directed immunoprecipitates 
from all the transfectants, irrespective of co-expression of the 
y chains. 
3.3. In vivo tyrosine phosphorylation fJAK3 in response to IL-2 
We previously reported that JAK1 and the 114 kDa JAK2- 
related molecules were tyrosine phosphorylated with IL-2 stim- 
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Fig. 3. Physical association of JAK1 and the 114 kD JAK2-related 
molecule with the IL-2R. Cells (1 x 10 s for lanes 1-11, 1 × 107 for lanes 
12 and 13) were lysed with digitonin cell extraction buffer. The y chain 
(lanes 1-5) and the fl chain (lanes 6-10) were immunoprecipitated from 
cell lysates of ED40515(-) (lanes 1 and 6), EDz-16 (lanes 2 and 7), 
EDydC30-4 (lanes 3and 8), EDzdC68-3 (lanes 4and 9) and EDydSH-I 
(lanes 5 and 10). For controls, immunoprecipitation was performed 
with PAR3 mAb (lane 11), anti-JAK1 antibody (lane 12) and anti- 
JAK2 antibody (lane 13) from cell lysate of ED40515(-). The im- 
munoprecipitates were separated by SDS-PAGE and blotted to a filter. 
The filter was then incubated with anti-JAK2 antibody (upper panel), 
followed by incubation with ~2Sl-labeled protein A. After stripping, the 
same filter was similarly incubated with anti-JAK1 antibody and then 
with ~2SI-labeled protein A (lower panel). Molecular sizes of standards 
(Mr × 10 -3) are indicated and the 114 kDa JAK2-related molecule and 
JAK 1 are also shown by a closed arrowhead and an arrow, respectively. 
Other JAK2-related molecules are indicated by open arrowheads. 
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Fig. 4. IL-2-induced tyrosine phosphorylation f JAK3 in the transfec- 
tants. Cells were stimulated with 10 nM IL-2 for 5 rain, lysed with the 
NP-40 cell extraction buffer and immunoprecipitated with anti-JAK2 
antibody. The immunoprecipitates w re separated by SDS-PAGE and 
blotted to a filter. The filter was incubated with anti-phosphotyrosine 
antibody and then with r2~l-labeled protein A (upper panel). After 
stripping, the same filter was similarly incubated with anti-JAK2 anti- 
body and ~2SI-labeled protein A (middle panel). After stripping, the 
same filter was similarly incubated with anti-rat JAK3 antibody and 
t2SI-labeled protein A (lower panel). Molecular sizes of standards 
(Mr X 10 -~) are indicated and the 114 kDa JAK2-related molecule 
(upper and middle panel) and JAK3 (lower panel) are shown by arrows. 
ulation on human T cell lines and phytohemagglutinin-stimu- 
lated human peripheral blood leukocyte [28]. Then we exam- 
ined the effects of IL-2 on phosphorylation f the 114 kDa 
JAK2-related molecule on the transfectants which express the 
mutant y chains. The 114 kDa JAK2-related molecules were 
immunoprecipitated with anti-JAK2 antibody, from lysates of 
the transfectants before and after IL-2 stimulation. The im- 
munoprecipitates were separated by SDS-PAGE and im- 
munoblotted with anti-phosphotyrosine antibody. IL-2 in- 
duced tyrosine phosphorylation f the 114 kDa JAK2- related 
molecule in EDy-16 and EDydC30-4 cells but not in EDydC68- 
3 and EDydSH-1 cells as well as ED40515(-) (Fig. 4, upper 
panel). The same membrane was probed with anti-JAK2 anti- 
body after stripping the anti-phosphotyrosine a tibody (Fig. 4, 
middle panel). Four bands (120, 114, 102 and 97 kDa) of JAK2- 
related molecules were seen with all the cell lines. Among the 
four bands, the second slowly migrating band (indicated by an 
arrow) was phosphorylated. Thus, again, only the 114 kDa 
JAK2-related molecule was shown to be tyro- 
sine-phosphorylated upon IL-2 stimulation. Very recently 
human L-JAK/JAK3 was cloned [30], and we noticed that the 
amino acid sequence of synthetic peptide for immunization of
mouse JAK2 (Asp758-Lys 776) was very similar to that of L-JAK/ 
JAK3 (Asp73°-Lys748). 14amino acids among the JAK2 syn- 
thetic peptide are identical to that of JAK3. So we examined 
if the 114 kDa JAK2-related molecule is identical to the JAK3 
or not. The same membrane was probed with anti-rat JAK3 
antibodies after stripping the anti-JAK2 antibody. The amino 
acid sequence of synthetic peptide of rat JAK3, which was used 
for immunization of rat JAK3, was almost similar to that of 
human JAK3 (13 amino acids of the 14-amino-acid synthetic 
peptide were identical to human JAK3). As expected, only one 
band of JAK3 with an apparent molecular mass of 114 kDa was 
seen with all the cell lines (Fig. 4, lower panel). The band was 
not detected in the presence of JAK3 synthetic peptide (data 
not shown). We then concluded that the 114 kDa JAK2- related 
molecule is identical to the JAK3, indicating that anti-JAK2 
antibody used crossreacts ohuman JAK2 and JAK3. Unfortu- 
nately, because the anti-rat JAK3 antibody could not im- 
munoprecipitate th  human JAK3, we immunoprecipitated the 
JAK3 with the anti- JAK2 antibody in the following study. 
3.4. In vitro phosphorylation of JAK3 
We assumed that tyrosine phosphorylation f JAK3 in re- 
sponse to IL-2 reflects activation of JAK3 kinase. The possibil- 
ity was examined by the in vitro kinase assay. The transfectants 
were precipitated with anti- JAK2 antibody before and after 
IL-2 stimulation, and the immunoprecipitates w re employed 
for the in vitro kinase assay with [y32p]ATP. IL-2 significantly 
affected phosphorylation f the JAK3 molecule from EDy- 16 
and EDTdC30-4 cells, but not from other transfectants and the 
parental ED40515(-) cells (Fig. 5A). Phosphoamino acid anal- 
ysis of the bands clearly indicated that in vitro phosphorylation 
of JAK3 after IL-2 stimulation was prominent on tyrosine 
residues (Fig. 5B). Similarly, JAK1 kinase activation was exam- 
ined, but it was undetectable in any of the transfectants tested 
(data not shown). 
Our results clearly demonstrated that the cytoplasmic SH2- 
like subdomain of the 7/ chain, which is essential for IL-2- 
mediated signaling for the induction of the c-myc gene and 
DNA synthesis, is required for association and activation of 
JAK3, while the region containing the C- terminal 30 amino 
acids of the ~ chain, which is essential for induction of the c-Jbs 
and c-jun genes but not induction of the c-myc gene and DNA 
synthesis, has no effect on the activation and association of 
JAK3 with the y chain. 
The two distinct signaling pathways from the IL-2 receptor, 
one for induction of the c-los and c-jun genes and the other for 
induction of the c-myc gene that correlates with cell growth 
promotion, were previously observed in transfectants with the 
fl and y chains [31,37]. The IL-2-mediated induction of the c-/~s 
and c-jun genes has been suggested to be accompanied with 
activation of the Src type tyrosine kinases uch as Lck, Fyn and 
Lyn, and activation of Ras and Raf-1 [16,38~,0]. The acidic 
region of the fl chain was found to be necessary for association 
of these src type tyrosine kinases [14,16]. However, IL-2-in- 
duced tyrosine phosphorylation f cellular proteins and cell 
proliferation were observed in transfectant cell lines expressing 
the ~ and y chains and the fl chain mutant lacking the acidic 
region (Ohbo et al., unpublished ata). These observations 
suggested that other tyrosine kinase(s) rather than the src type 
tyrosine kinases may participate in IL-2-mediated cell growth 
signal transduction. 
Intriguingly, the present study demonstrated that JAK3 as- 
sociation with the y chain and activation of JAK3 can be 
separated from the IL-2-mediated signal transduction pathway 
for induction of the c-los and c-jun genes, rather association and 












Fig. 5. In vitro phosphorylation f JAK3. Cells were stimulated with 
10 nM IL-2 for 5 min, lysed with the NP-40 cell extraction buffer and 
immunoprecipitated with anti-JAK2 antibody. The immunoprecipi- 
tates were subjected to in vitro immunecomplex kinase assays (A). 
Molecular sizes of standards (Mr × 10 -3) are indicated and JAK3 bands 
are shown by arrow. Bands corresponding to JAK3 from EDy-16 and 
EDydC30-4 cells before and after IL-2 stimulation was excised from 
the gel and examined for phosphoamino acids (B). Positions of 
phosphoserine (S), phosphothreonine (T) and phosphotyrosine (Y) are 
shown. 
activation of JAK3 parallels induction of the c-myc gene and 
DNA synthesis. Thus, JAK3 is suggested to play crucial roles 
in IL-2- mediated signal transduction for induction of c-myc 
mRNA followed by DNA synthesis. 
There is accumulating evidence that JAK-Tyk kinases are 
tyrosine-phosphorylated upon stimulation with many cytoki- 
nes. IFNct/fl, IFNy, IL-6, LIF, OSM and CNTF-induced sig- 
nals involve two distinct members of the JAK-Tyk family. Two 
members associated with receptors for such cytokines are 
thought o be essential for signal transduction mediated by 
ligands. In the case of IL-2, similar to these cytokines, JAK1 
and JAK3 link to the fl and y chains, respectively, even in the 
absence of IL-2. And the previous and the present results ug- 
gested that both of these kinases eem to be essential for IL-2- 
induced cell growth signaling [28]. 
Abnormality of the 7/chain is closely related to X- linked 
severe combined immunodeficiency (XSCID) characterized by 
impairment of early T cell development [41]. Mysteriously I L- 
2-deficient mice did not show XSCID concomitant phenotypes 
[42]. Recent studies may, however, pave the way to dissolve the 
discrepancy. We and others demonstrated that the y chain is 
shared by receptors for interleukin 4 (IL-4) and interleukin 7 
(IL-7) [43--46]. Thus cytokines which recruit the ?' chain as a 
receptor subunit are possible candidates of which dysfunction 
induces impairment of early T cell development in XSCID. 
Indeed, IL-4 and IL-7 are shown to have effects on T cells. 
Collectively, JAK3 is assumed to be involved in signal 
transduction from the IL-4 receptor and IL-7 receptor, similar 
to the IL-2 receptor. Our preliminary experiment indicated that 
IL-4 and IL-7 induce tyrosine phosphorylation of JAK3 
(Tanaka et al., unpublished data). So we are very interested in
the phenotype of JAK3 knock out mice besides of the y chain 
knock out mice. Next questions to be addressed are how spe- 
cific these receptors including the y chain and JAK family 
members transduce signals. Although we have not yet defined 
signal transducers associated with the cz chains of IL-4R and 
IL-7R, it is also possible that they associate with other members 
of the JAK-Tyk family, such as JAK1, Tyk2 or other members, 
like other cytokine receptors mentioned above. The IL-2Rfl 
chain, IL- 4Rcz chain and IL-7Rcz chain may transduce specific 
signals depending on ligands, while the y chain may generate 
signals common to ligands. Two signal pathways uch as JAK 1 
and JAK3 in IL-2-mediated signals may interact with each 
other, resulting in complete ligand-dependent signal transduc- 
tion. Identification of substrates for IL-2-, IL-4- or IL-7-acti- 
vated JAK3 will be necessary to see the functional roles of the 
JAK-Tyk family in lymphokine signal transduction system. 
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